Atlas Trials

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

Clinical trial NCT07682792 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07682792
Sponsor
Washington University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mycosis Fungoides/Sezary SyndromeT-cell Large Granular Lymphocytic Leukemia
Start date
2026-09-30
Primary completion
2030-01-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.